LAGUNA HILLS, Calif. – Patients of Orange County Urology Associates (OCUA) have never heard of the term G11, but it helps lower costs of the urology services they receive from OCUA.
G11 is a group alliance of eleven Orange County medical organizations. They have joined forces to exchange clinical management knowledge, realize group purchasing benefits, and share medical business insights with other member organizations.
Download our summer newsletter to learn about the latest urology and health care related stories at Orange County Urology Associates . This season’s newsletter features the following articles:
- Enlarged prostate: Key facts you should know
- Why we believe men should be screened for prostate cancer using the PSA test
- The art of good patient-physician communication
- FDA approves Botox for patients with neurogenic
- Josh Randall, M.D., joins physician staff of OCUA
- OCUA to open new satellite office in Irvine near Irvine Hoag Hospital
LAGUNA HILLS, Calif. — The U.S. Preventive Services Task Force has recommended that healthy men should no longer receive prostate-specific antigen (PSA) blood tests as part of routine cancer screening. This recommendation has been picked up by many news organizations, and this has caused a great deal of confusion among men throughout the United States.
Dr. Neyssan Tebyani of OCUA was featured on American Health Journal to discuss the diagnosis and treatment of prostate cancer. During his interview he discuss the the diagnosis of prostate cancer and benefits of using robotic surgery to treat the cancer.